Legal Representation
Attorney
Jeannine Rittenhouse
USPTO Deadlines
Next Deadline
2870 days remaining
Section 8 & 9 (40-Year) Renewal Due (Based on registration date 1993-05-18)
Due Date
May 18, 2033
Grace Period Ends
November 18, 2033
Application History
39 eventsDate | Code | Type | Description |
---|---|---|---|
Nov 22, 2023 | ASCK | I | ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY |
Jan 25, 2023 | 89AG | O | REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED |
Jan 25, 2023 | RNL3 | Q | REGISTERED AND RENEWED (THIRD RENEWAL - 10 YRS) |
Jan 25, 2023 | NA89 | E | NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED |
Jan 23, 2023 | APRE | A | CASE ASSIGNED TO POST REGISTRATION PARALEGAL |
Jul 7, 2022 | E89R | I | TEAS SECTION 8 & 9 RECEIVED |
May 18, 2022 | REM2 | E | COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED |
Feb 26, 2020 | ASGN | I | AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP |
Nov 28, 2018 | REAP | I | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
Nov 28, 2018 | ARAA | I | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
Mar 15, 2017 | ASCK | I | ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY |
Feb 22, 2017 | ASCK | I | ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY |
Aug 3, 2016 | ASGN | I | AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP |
Dec 3, 2013 | APRE | A | CASE ASSIGNED TO POST REGISTRATION PARALEGAL |
Dec 3, 2013 | 89AG | O | REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED |
Dec 3, 2013 | RNL2 | Q | REGISTERED AND RENEWED (SECOND RENEWAL - 10 YRS) |
Dec 3, 2013 | NA89 | E | NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED |
Nov 15, 2013 | E89R | I | TEAS SECTION 8 & 9 RECEIVED |
Nov 15, 2013 | 89AF | I | REGISTERED - COMBINED SECTION 8 (10-YR) & SEC. 9 FILED |
Aug 17, 2011 | ASCK | I | ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY |
Feb 12, 2009 | CFIT | O | CASE FILE IN TICRS |
Jul 31, 2003 | 89AG | O | REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED |
Jul 31, 2003 | RNL1 | Q | REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS) |
May 16, 2003 | E89R | I | TEAS SECTION 8 & 9 RECEIVED |
May 16, 2003 | 89AF | I | REGISTERED - COMBINED SECTION 8 (10-YR) & SEC. 9 FILED |
Sep 25, 1999 | C15A | O | REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK. |
Apr 16, 1999 | 815F | I | REGISTERED - SEC. 8 (6-YR) & SEC. 15 FILED |
May 18, 1993 | R.PR | A | REGISTERED-PRINCIPAL REGISTER |
Mar 18, 1993 | CNPR | P | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED |
Mar 4, 1993 | CNRT | S | NON-FINAL ACTION MAILED |
Feb 22, 1993 | EX1G | S | SOU EXTENSION 1 GRANTED |
Feb 22, 1993 | SUPC | I | STATEMENT OF USE PROCESSING COMPLETE |
Jan 19, 1993 | EXT1 | S | SOU EXTENSION 1 FILED |
Jan 19, 1993 | IUAF | S | USE AMENDMENT FILED |
Jul 21, 1992 | NOAM | O | NOA MAILED - SOU REQUIRED FROM APPLICANT |
Apr 28, 1992 | PUBO | A | PUBLISHED FOR OPPOSITION |
Mar 27, 1992 | NPUB | O | NOTICE OF PUBLICATION |
Nov 7, 1991 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER |
Oct 31, 1991 | DOCK | D | ASSIGNED TO EXAMINER |
Detailed Classifications
Class 005
diagnostic radiopharmaceuticals
First Use Anywhere:
Jan 8, 1993
First Use in Commerce:
Jan 8, 1993
Additional Information
Pseudo Mark
OCTREOSCAN
Classification
International Classes
005